KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Change in Inventory (2016 - 2020)

Thermo Fisher Scientific's Change in Inventory history spans 12 years, with the latest figure at $81.0 million for Q4 2020.

  • For the quarter ending Q4 2020, Change in Inventory rose 800.0% year-over-year to $81.0 million, compared with a TTM value of $508.0 million through Dec 2020, up 10.92%, and an annual FY2025 reading of $74.0 million, up 174.07% over the prior year.
  • Change in Inventory for Q4 2020 was $81.0 million at Thermo Fisher Scientific, down from $118.0 million in the prior quarter.
  • The five-year high for Change in Inventory was $176.0 million in Q3 2019, with the low at -$127.0 million in Q4 2017.
  • Average Change in Inventory over 5 years is $63.6 million, with a median of $76.0 million recorded in 2018.
  • Year-over-year, Change in Inventory tumbled 190.6% in 2016 and then skyrocketed 800.0% in 2020.
  • Tracing TMO's Change in Inventory over 5 years: stood at -$75.7 million in 2016, then plummeted by 67.77% to -$127.0 million in 2017, then surged by 92.91% to -$9.0 million in 2018, then skyrocketed by 200.0% to $9.0 million in 2019, then skyrocketed by 800.0% to $81.0 million in 2020.
  • Per Business Quant, the three most recent readings for TMO's Change in Inventory are $81.0 million (Q4 2020), $118.0 million (Q3 2020), and $168.0 million (Q2 2020).